Patent · US Active

Solid state forms of N-((S)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide

US9260393B2 · kind B2 · utility

0Cited by

4References

16Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Axel Becker · Altrip, DE
Christoph Saal · Otzberg, DE
Clemens Kuehn · Darmstadt, DE
Donald Bankston · Dracut, US
Marco Poma · Grosseto, IT

Key dates

Filing date	May 7, 2013
Grant date	Feb 16, 2016
Priority date	—
Expiry date	May 7, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to solid state forms of N—((S)-2,3-Dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide, processes for their preparation, and medical uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.